Wrinkle-Filling Market-Leader Medicis Ready To Take On Juvederm
This article was originally published in The Gray Sheet
Executive Summary
Medicis says the superior formulation of its Restylane dermal filler will enable it to fend off looming competition from a lower-priced offering by pharmaceutical powerhouse Allergan